LG to export technologies of new drug for B viral hepatitis.
Published: 2004-04-21 06:58:00
Updated: 2004-04-21 06:58:00
LG Life Science Co. has developed a new drug for the treatment of B viral hepatitis under the code of B80380 and tried to explore a strategic business tie-up with Anadys Corp. of America for an earlier commercialization in the world market.
For this purpose LG Life Science has made an agreement...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
